On November 22, 2024, the VIROFIGHT Symposium brought together...

VIROFIGHT Symposium on Antiviral Biologics
On November 22, 2024, the VIROFIGHT Symposium brought together scientific experts in antiviral biologics to present the results and achievements of our VIROFIGHT project. Held in a hybrid format at the Science Congress Center in Garching, the event featured over 50 participants and two main sessions: “VIROFIGHT Results and Achievements” and “Pathways to Novel Antiviral Treatments.”
The symposium highlighted innovative antiviral strategies off the beaten paths, including virus-neutralizing nano-shells, DNA origami, protein minibinders and neutralization assays. Further the Symposium features four external guest speakers:
- Prof Maartje Basting from EPFL talked about “Super-Selective Biomaterials in Action – Balancing geometry and rigidity at the biointerface”
- Dr. Alba Monferrer, CPTx, Head of preclinical development and PMO talked abouut CPTx’s “Pathogen-Agnostic Viral Countermeasure Platform”
- Prof Rainer Haag, FU Berlin talked about “„Supramolecular Nanosystems for the Inhibition of Viruses”
- Prof Emma Chory with her talk on “Navigating the Evolution Multiverse: Decoding Path Decisions of Affinity and Specificity”
Attendees engaged in discussions, networking opportunities, and interactive Q&A sessions, fostering further collaboration.
Recordings of the VIROFIGHT results and achievements will soon be available.

Attendees from left to right: Hendrik Dietz (TUM, Coordinator), Jørgen Kjems (AU), Alba Monferrer (CPTx), Maartje Basting (EPFL), Rainer Haag (FU), Emma Chory (Duke University), Ulrike Protzer (TUM) and Ralf Wagner (UREG)